标题 |
[高分] 专利、报告等 Nemolizumab monotherapy improves itch and skin lesions in patients with moderate-to-severe prurigo nodularis: Results from a global phase 3 trial (OLYMPIA 1)
Nemolizumab单药治疗可改善中度至重度结节性痒疹患者的瘙痒和皮肤损害:来自全球3期试验的结果(OLYMPIA 1)
|
网址 | |
DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
求助人 | |
下载 |